Recent Advances of Immune Checkpoint Inhibition and Potential for (Combined) TIGIT Blockade as a New Strategy for Malignant Pleural Mesothelioma

Malignant pleural mesothelioma (MPM) is a fatal cancer type that affects the membranes lining the lungs, and is causally associated with asbestos exposure. Until recently, the first-line treatment consisted of a combination of chemotherapeutics that only had a limited impact on survival, and had not...

Full description

Bibliographic Details

Published in:	Biomedicines
Main Authors:	Sophie Rovers, Annelies Janssens, Jo Raskin, Patrick Pauwels, Jan P. van Meerbeeck, Evelien Smits, Elly Marcq
Format:	Article
Language:	English
Published:	MDPI AG 2022-03-01
Subjects:	mesothelioma cancer immunotherapy immune checkpoint blockade TIGIT PD-L1
Online Access:	https://www.mdpi.com/2227-9059/10/3/673